Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000143

Options or other derivatives

  • Chief Financial Officer acquired 1,250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Davis Blaine Chief Financial Officer 2022-11-28 Grant or award · Employee Stock Option (right to buy) +1,250,000 1,250,000 D
Loading xslF345X03/wf-form4_166984440599363.xml…